Physician profile
Martin A Urban
NPI 1871744276
$2,221.96
in general payments reported to CMS, 2019-2025
9 companies · $360 in 2025
The $360 reported for 2025 was more than what 87% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $165 · 2021: $336 · 2022: $305 · 2023: $362 · 2024: $268 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.44 |
| Education | $181.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $1,073.00 | 2019-2024 | |
| Dentsply Sirona INC | $574.16 | 2019-2025 | Astra Tech Implant System, Atlantis, Consumable Dentistry |
| Straumann USA LLC | $312.73 | 2022-2025 | |
| Zest Holdings, LLC | $101.51 | 2024 | |
| Align Technology, INC. | $75.69 | 2021 | |
| Zimmer Biomet Holdings, INC. | $32.00 | 2019 | |
| Ultradent Products INC | $21.66 | 2019 | |
| Voco America INC. | $18.92 | 2024 | Futurabond U, Meron Plus Qm, Grandio So Heavy Flow |
| Orapharma, A Division of Bausch Health US, LLC | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Urban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.